Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Griscelli syndrome: a model system to study vesicular trafficking.
Van Gele M, Dynoodt P, Lambert J. Van Gele M, et al. Among authors: dynoodt p. Pigment Cell Melanoma Res. 2009 Jun;22(3):268-82. doi: 10.1111/j.1755-148X.2009.00558.x. Epub 2009 Feb 25. Pigment Cell Melanoma Res. 2009. PMID: 19243575 Review.
Identification of miR-145 as a key regulator of the pigmentary process.
Dynoodt P, Mestdagh P, Van Peer G, Vandesompele J, Goossens K, Peelman LJ, Geusens B, Speeckaert RM, Lambert JL, Van Gele MJ. Dynoodt P, et al. J Invest Dermatol. 2013 Jan;133(1):201-9. doi: 10.1038/jid.2012.266. Epub 2012 Aug 16. J Invest Dermatol. 2013. PMID: 22895360 Free article.
Lipid-mediated gene delivery to the skin.
Geusens B, Strobbe T, Bracke S, Dynoodt P, Sanders N, Van Gele M, Lambert J. Geusens B, et al. Among authors: dynoodt p. Eur J Pharm Sci. 2011 Jul 17;43(4):199-211. doi: 10.1016/j.ejps.2011.04.003. Epub 2011 Apr 16. Eur J Pharm Sci. 2011. PMID: 21515366 Review.
Comprehensive DNA methylation study identifies novel progression-related and prognostic markers for cutaneous melanoma.
Wouters J, Vizoso M, Martinez-Cardus A, Carmona FJ, Govaere O, Laguna T, Joseph J, Dynoodt P, Aura C, Foth M, Cloots R, van den Hurk K, Balint B, Murphy IG, McDermott EW, Sheahan K, Jirström K, Nodin B, Mallya-Udupi G, van den Oord JJ, Gallagher WM, Esteller M. Wouters J, et al. Among authors: dynoodt p. BMC Med. 2017 Jun 5;15(1):101. doi: 10.1186/s12916-017-0851-3. BMC Med. 2017. PMID: 28578692 Free PMC article.
Low expression of pro-apoptotic proteins Bax, Bak and Smac indicates prolonged progression-free survival in chemotherapy-treated metastatic melanoma.
Guttà C, Rahman A, Aura C, Dynoodt P, Charles EM, Hirschenhahn E, Joseph J, Wouters J, de Chaumont C, Rafferty M, Warren M, van den Oord JJ, Gallagher WM, Rehm M. Guttà C, et al. Among authors: dynoodt p. Cell Death Dis. 2020 Feb 13;11(2):124. doi: 10.1038/s41419-020-2309-3. Cell Death Dis. 2020. PMID: 32054850 Free PMC article.
Prognostic and predictive biomarkers in melanoma: an update.
Foth M, Wouters J, de Chaumont C, Dynoodt P, Gallagher WM. Foth M, et al. Among authors: dynoodt p. Expert Rev Mol Diagn. 2016;16(2):223-37. doi: 10.1586/14737159.2016.1126511. Epub 2015 Dec 22. Expert Rev Mol Diagn. 2016. PMID: 26620320 Review.
Apelin: A putative novel predictive biomarker for bevacizumab response in colorectal cancer.
Zuurbier L, Rahman A, Cordes M, Scheick J, Wong TJ, Rustenburg F, Joseph JC, Dynoodt P, Casey R, Drillenburg P, Gerhards M, Barat A, Klinger R, Fender B, O'Connor DP, Betge J, Ebert MP, Gaiser T, Prehn JHM, Griffioen AW, van Grieken NCT, Ylstra B, Byrne AT, van der Flier LG, Gallagher WM, Postel R. Zuurbier L, et al. Among authors: dynoodt p. Oncotarget. 2017 Jun 27;8(26):42949-42961. doi: 10.18632/oncotarget.17306. Oncotarget. 2017. PMID: 28487489 Free PMC article.
12 results